RT info:eu-repo/semantics/article
T1 The addition of diacutaneous fibrolysis to a pharmacological Iitervention in patients with tension-type headache: A randomized controlled trial
A1 Cabanillas Barea, Sara
A1 Ceballos Laita, Luis
A1 Pérez Guillén, Silvia
A1 Jiménez del Barrio, Sandra
A1 Pardos Aguilella, Pilar
A1 Rodríguez Rubio, Pere Ramón
A1 Carrasco Uribarren, Andoni
K1 Headache - Treatment
K1 Cefalea - Tratamiento
K1 Cefalalgia - Tratamiento
K1 Dolor de cabeza - Tratamiento
K1 Pharmacology
K1 Medicamentos
K1 Quality of life
K1 Calidad de vida
K1 Outcome assessment (Medical care)
K1 Atención médica
K1 32 Ciencias Médicas
K1 3209 Farmacología
AB Background: Tension-type headache (TTH) is the most common headache worldwide. Pharmacological interventions are the most investigated therapies in patients with TTH. The addition of physical therapy treatments such as diacutaneous fibrolysis (DF) may have promising results. The aim of this study was to investigate the addition of three sessions of DF to a pharmacological intervention in patients with TTH. Methods: A single-blinded randomized controlled trial was carried out. Participants were randomly assigned to the standard care group or to the DF group. Both groups received a pharmacological intervention. Three sessions of DF in the thoracic and cervicocranial region were added in the DF group. The impact caused by headache (HIT-6), headache intensity, and cervical range of motion were measured by blinded assessors at baseline, after the intervention, and at 1 month follow-up. Results: Eighty-two patients with TTH were included (41 standard care group; 41 DF group). Statistically significant differences were found between both groups in all the variables after the intervention and at 1 month follow-up (p < 0.001). No adverse effects or side-effects were reported during the study. Conclusions: The addition of three sessions of DF to a pharmacological therapy provided improvements in the impact caused by headache, headache intensity, and cervical range of motion after the intervention and at 1 month follow-up compared to a pharmacological therapy in isolation. Further research is needed to investigate long-term effects.
PB MDPI
SN 2077-0383
YR 2022
FD 2022
LK https://uvadoc.uva.es/handle/10324/60168
UL https://uvadoc.uva.es/handle/10324/60168
LA eng
NO Journal of Clinical Medicine, 2022, Vol. 11, Nº. 22, 6716
NO Producción Científica
DS UVaDOC
RD 09-may-2025